Kilroy Realty
Leases and manages office, life-science, mixed-use, and residential properties in selected U.S. markets.
Something off on this page? Send us feedback.
Profile
Leases and operates office, life-science, mixed-use, and residential properties across selected U.S. markets. Operates as a self-administered REIT with one reportable operating segment.
Leases and operates office, life-science, mixed-use, and ancillary residential space. Its portfolio is concentrated in Greater Los Angeles, San Diego, the San Francisco Bay Area, the Pacific Northwest/Seattle, and Austin.
Operates as a self-administered REIT, managing its portfolio rather than selling consumer products. The public company began operations through a 1997 IPO after a predecessor real-estate business founded in 1947.
Portfolio activity includes development, acquisition, and management, including additions in Torrey Pines and Beverly Hills. Leasing and operating these property types in selected U.S. markets are core business dependencies, and the company reports one operating segment.
Company facts
Categories
Key statistics
Year to date −4.7% · Average volume (30d) 1.2M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Goldman Sachs | Reiterate | Sell | $75 | $31 | |
| Jul 21, 2026 | Scotiabank | Reiterate | Sector Perform | $38 | $41 | |
| Jul 21, 2026 | Mizuho Securities | Target | $29 | $34 | ||
| Jul 21, 2026 | Barclays | Reiterate | Equal Weight | $39 | $38 | |
| Jun 16, 2026 | UBS | Target | $44 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026Q2 FY26 | $0.15 | $0.17 | +15.4% | $267.4M | $272.4M | +1.9% | −1.90% |
| Apr 27, 2026Q1 FY26 | $0.14 | $0.91 | +543.6% | $263.1M | $270.1M | +2.7% | +4.28% |
| Feb 9, 2026Q4 FY25 | $0.29 | $0.10 | −65.7% | $271.2M | $272.2M | +0.4% | −3.73% |
| Oct 27, 2025Q3 FY25 | $1.00 | $1.09 | +9.0% | $269.9M | $279.7M | +3.6% | +1.75% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $270.8M | $289.9M | $279.7M | $272.2M | $270.1M | $272.4M | |
| Gross profit | $177.9M | $199.3M | $186.5M | $181.9M | −$13.2M | $177.8M | |
| Operating income | $73.9M | $93.2M | $80.7M | $67.8M | $60.7M | $65.4M | |
| Net income | $39.0M | $68.4M | $156.2M | $12.4M | −$19.3M | $19.9M | |
| Diluted EPS | $0.33 | $0.57 | $1.31 | $0.11 | −$0.16 | $0.17 | |
| Gross margin | 65.7% | 68.7% | 66.7% | 66.8% | -4.9% | 65.3% | |
| Operating margin | 27.3% | 32.1% | 28.9% | 24.9% | 22.5% | 24.0% |
Fiscal years (4-quarter sums)FY21 $955.0M · FY22 $1.10B · FY23 $1.13B · FY24 $1.14B · FY25 $1.11B
Balance sheet, Jun 30, 2026Cash & short-term investments $288.8M · Total debt $4.66B · Total assets $10.63B · Shareholders' equity $5.23B
Dividends
Raised for 16 straight years — most recently to $0.54 from $0.52 in Sep 2022. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 30, 2026 | Jun 30 | Jul 8 | $0.54 | |
| Mar 31, 2026 | Mar 31 | Apr 8 | $0.54 | |
| Dec 31, 2025 | Dec 31 | Jan 7 | $0.54 | |
| Sep 30, 2025 | Sep 30 | Oct 8 | $0.54 | |
| Jun 30, 2025 | Jun 30 | Jul 9 | $0.54 | |
| Mar 31, 2025 | Mar 31 | Apr 9 | $0.54 | |
| Dec 31, 2024 | Dec 31 | Jan 8 | $0.54 | |
| Sep 30, 2024 | Sep 30 | Oct 9 | $0.54 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 116.31M · Float 114.98M · 98.9% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.51M | 13.33% | 13F | Aug 7, 2026 |
| D1 Capital Partners L.P. | 10.50M | 9.03% | 13F | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 9.58M | 8.23% | 13F | Aug 13, 2026 |
| State Street Corp | 6.13M | 5.27% | 13F | Aug 7, 2026 |
| Cohen & Steers, Inc. | 5.77M | 4.96% | 13F | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 29, 2026 | Jolie A. Hunt | director | −15,800 | $37.79 |
| Jun 24, 2026 | A. Robert Paratte | officer: See Remarks | −8,000 | $37.34 |
| Jun 9, 2026 | Justin William Smart | officer: President | −10,848 | $38.71 |
| May 7, 2026 | Heidi Rena Roth | officer: See Remarks | −19,541 | $35.22 |
| May 6, 2026 | Lauren N. Stadler | officer: See Remarks | −3,000 | $34.65 |
Peers
- Hudson Pacific Properties
West Coast office leasing for technology and media tenants
- Douglas Emmett
Los Angeles Class A office and multifamily leasing
- Alexandria Real Estate Equities
Life-science campus leasing in San Diego, the Bay Area, and Seattle
- Healthpeak Properties
Lab and life-science real estate in San Francisco and San Diego
- BXP
Premier workplace and lab leasing in San Francisco
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Kilroy Realty | $36.21 | −0.03% | $4.21B | 25.3 | 86.1 | 3.8 | −6.0% |
| Hudson Pacific Properties | $13.14 | −0.23% | $712.7M | — | — | 0.9 | −0.9% |
| Douglas Emmett | $11.76 | 0.00% | $1.97B | — | — | 2.0 | +1.6% |
| Alexandria Real Estate Equities | $51.98 | +0.81% | $8.99B | — | — | 3.0 | −15.6% |
| Healthpeak Properties | $20.79 | −0.79% | $14.45B | 59.9 | 101.1 | 4.9 | +8.0% |
| BXP | $68.89 | −0.61% | $11.05B | 37.3 | 33.8 | 3.1 | +3.1% |
| Median | 48.6 | 67.5 | 3.0 | +1.6% |